newscaster

Get Ready to Level Up Your Security Game: Sectigo Takes the Spotlight at Gartner’s Risk Management Summit 2023!

Sectigo Platinum Sponsor of Gartner Security & Risk Management Summit 2023 Sectigo Executives Highlight the Importance of Certificate Lifecycle Management ROSELAND, N.J., Sept. 26, 2023 (GLOBE NEWSWIRE) — Sectigo®, a global leader in automated Certificate Lifecycle Management (CLM) and digital certificates, announced its sponsorship and speaking engagement at the Gartner Security & Risk Management Summit…

Read More

Attention Investors: Don’t Miss Out on Your Chance to Secure Counsel Before the Deadline! A Quirky Reminder from Rosen & Co.

Don’t Miss Out on the Lead Plaintiff Deadline for Applied Digital Corporation Investors! Act Now to Protect Your Rights Hey there, all you savvy investors out there! Have you heard the latest news about Applied Digital Corporation (NASDAQ: APLD)? If you’ve purchased securities of APLD between April 13, 2022, and July 26, 2023, then listen…

Read More

Uncovering the Untold Story: How NRM’s Rural Transformation Journey Neglects the Forgotten Farmers

The ongoing political rancor over alleged neglect of Luwero Triangle, the beacon of NRM revolution The ongoing political rancor over alleged neglect of Luwero Triangle, the beacon of NRM revolution, compels my recollection into Uganda’s rural transformation journey since 1987 when government in a fanfare launched the now forgotten Rural Farmer’s Scheme, and along with…

Read More

Kromatid Partners with Scientist.com to Advance IND Package Pipeline Program

Program offers drug researchers the ability to bundle multiple IND-enabling services from top-rated suppliers SAN DIEGO, Sept. 25, 2023 /PRNewswire-PRWeb/ — KromaTiD, a leader in single-cell genomic analysis, is pleased to announce a collaboration with Scientist.com, the go-to marketplace for pharmaceutical research and development. This partnership integrates KromaTiD into Scientist.com’s IND Package Pipeline Program, a…

Read More

Clever, Personable, and Unconventional: Affamed Therapeutics’ Risuteganib Luminate Receives Clinical Trial Approval in Mainland China for Intermediate Dry AMD Treatment

Exciting News from AffaMed Therapeutics A Global Leader in Biotechnology SHANGHAI, Sept. 25, 2023 /PRNewswire/ — AffaMed Therapeutics (“AffaMed”), a global biotechnology company dedicated to developing and commercializing transformative pharmaceutical, digital and surgical products that address critical unmet medical needs in ophthalmological, neurological and psychiatric disorders, today announced that China’s National Medical Products Administration has…

Read More

China Takes the Lead in Uganda’s Oil Pipeline Project: Western Financiers Step Back, But Don’t Worry – China’s Got This!

China Takes the Lead in Uganda’s Oil Pipeline Project as Western Financiers Step Back In a surprising turn of events, China has emerged as the savior for Uganda’s ambitious oil pipeline project, stepping in after major Western banks withdrew their support amidst mounting environmental concerns. The East African Crude Oil Pipeline (EACOP), slated to connect…

Read More

Innovative and Articulate: LambdaTest Unveils Comprehensive Diversity, Equity, and Inclusion Plan

LambdaTest Launches Diversity, Equity, and Inclusion Policy San Francisco, Sept. 21, 2023 (GLOBE NEWSWIRE) — LambdaTest, a leading cloud-based unified testing platform, has recently announced the launch of its Diversity, Equity, and Inclusion (DEI) Policy. This move signifies LambdaTest’s dedication to creating a workplace that values diversity, equality, and inclusion. By implementing this policy, LambdaTest…

Read More